Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)
This is a contract result notice, not an open opportunity. Details from the official award data.
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions.
The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card.
The blood sample is analysed by one of 13 newborn screening laboratories in England
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card.
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- b799e693-eab3-4435-a855-4f8f34619110
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-3150800D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network